By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120



Drug Discovery

Company News
Cellectar Biosciences  (NVLT) Appoints Jarrod Longcor Senior Vice President Of Corporate Development And Operations 7/20/2016 8:52:07 AM
Cellectar Biosciences  (NVLT) Announces Results Of NCI-Sponsored Study Of CLR 125 Showing Potential Effect Against Triple Negative Breast Cancer 6/23/2016 7:53:47 AM
Cellectar Biosciences  (NVLT) Announces Positive Data From Phase I Therapeutic Trial Of CLR 131 In Multiple Myeloma 1/5/2016 8:14:22 AM
Cellectar Biosciences  (NVLT) And Pierre Fabre Announce Oncology Research Collaboration 12/16/2015 10:28:47 AM
Cellectar Biosciences  (NVLT) To Provide Update On Phase I Multiple Myeloma Study 12/9/2015 7:22:06 AM
Cellectar Biosciences  (NVLT) Chief Scientific Officer Receives International Recognition For Pioneering Research 11/20/2015 8:00:58 AM
Cellectar Biosciences  (NVLT) Announces Third Quarter Financial Results 11/13/2015 10:00:05 AM
Cellectar Biosciences  (NVLT) Converts Patent Application For Phospholipid-Ether Analogs As Cancer Targeting Drug Vehicles 11/10/2015 7:51:57 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On November 12th To Discuss Third Quarter Financial Results And Provide Clinical Development Program Update 11/5/2015 10:16:32 AM
Cellectar Biosciences  (NVLT) Provides Phospholipid Drug Conjugate (PDC) Platform Development Update 11/2/2015 7:43:12 AM